99mTc-labeled porphyrin-lipid nanovesicles

Journal of Liposome Research

Volumn 25, Issue 2, 2015, Pages 101-106

  Lee, Jae Ho ^a   Shao, Shuai ^b   Cheng, Kenneth T ^a   Lovell, Jonathan F ^b   Paik, Chang H ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b University at Buffalo The State University of New York   (United States)

Author keywords

99mTc labeled porphyrin lipid nanovesicles; Drug encapsulated liposome; Nanotechnology; Size exclusion analysis; Sustained release

Indexed keywords

CALCEIN; LIPOSOME; NANOPARTICLE; PORPHYRIN; PORPHYRIN LIPID NANOVESICLE TC 99M; TECHNETIUM 99M; UNCLASSIFIED DRUG; LIPID; NANOMATERIAL; TECHNETIUM;

ARTICLE; ELUTION; ISOTOPE LABELING; LIPID VESICLE; LIQUID CHROMATOGRAPHY; NANOENCAPSULATION; PRIORITY JOURNAL; RADIOACTIVITY; RADIOCHEMISTRY; SIZE EXCLUSION CHROMATOGRAPHY; THIN LAYER CHROMATOGRAPHY;

LIPIDS; NANOSTRUCTURES; PORPHYRINS; TECHNETIUM;

EID: 84942917077     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2014.932379     Document Type: Article

References (25)

1. Arulsudar N, Subramanian N, Mishra P., et al. (2003). Preparation, characterisation and biodistribution of 99mTc-labeled liposome encapsulated cyclosporine. J Drug Target 11:187-96.
2. Carter KA, Shao S, Hoopes M.I., et al. (2014). Porphyrin-phospholipid liposomes permeabilized by near-infrared light. Nat Commun 5:3546. doi:10.1038/ncomms4546.
3. Chang HI, Yeh MK (2012). Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. Int J Nanomed 7:49-60.
4. Conway J. (2012). Lung imaging - two dimensional gamma scintigraphy, SPECT, CT and PET. Adv Drug Deliv Rev 64:357-68.
5. Elbayoumi TA, Torchilin VP (2006). Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies. Eur J Nucl Med Mol Imaging 33:1196-205.
6. Ellis GA, Mcgrath NA, Palte M.J., Raines RT. (2012). Ribonuclease-activated cancer prodrug. ACS Med Chem Lett 3:268-72.
7. Farr SJ, Kellaway IW, Parryjones D.R., Woolfrey SG. (1985). Technetium-99M as a marker of liposomal deposition and clearance in the human-lung. Int J Pharm 26:303-16.
8. Goga L, Pushpakumar SB, Perez-Abadia G, et al. (2011). A novel liposome-based therapy to reduce complement-mediated injury in revascularized tissues. J Surg Res 165:e51-7.
9. 2 spheres synthesized via a "water-controlled release process". Nanoscale 5: 8184-91.
10. Jin CS, Lovell JF, Chen J, Zheng G. (2013). Ablation of hypoxic tumors with dose-equivalent photothermal, but not photodynamic, therapy using a nanostructured porphyrin assembly. ACS Nano 7:2541-50.
11. Koizumi K, Uchiyama G, Arai T., et al. (1992). A new liver functional study using Tc-99m DTPA-galactosyl human serum albumin: evaluation of the validity of several functional parameters. Ann Nucl Med 6:83-7.
12. Lee J, Park J, Singha K., Kim WJ. (2013a). Mesoporous silica nanoparticle facilitated drug release through cascade photosensitizer activation and cleavage of singlet oxygen sensitive linker. Chem Commun (Camb) 49:1545-7.
13. Lee JH, Cheng KT, Malinin V, et al (2013b). (99m)Tc-labeled therapeutic inhaled amikacin loaded liposomes. J Liposome Res 23: 336-42.
14. Liu TW, Macdonald TD, Shi J, et al (2012). Intrinsically copper-64-labeled organic nanoparticles as radiotracers. Angew Chem Int Ed Engl 51:13128-31.
15. Lovell JF, Jin CS, Huynh E, et al (2011). Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat Mater 10:324-32.
16. Malam Y, Loizidou M, Seifalian AM (2009). Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci 30:592-9.
17. Ng KK, Lovell JF, Vedadi A, et al (2013). Self-assembled porphyrin nanodiscs with structure-dependent activation for phototherapy and photodiagnostic applications. ACS Nano 7:3484-90.
18. Phillips WT. (1999). Delivery of gamma-imaging agents by liposomes. Adv Drug Deliv Rev 37:13-32.
19. Richardson VJ, Ryman BE, Jewkes R.F., et al. (1979). Tissue distribution and tumour localization of 99m-technetium-labelled liposomes in cancer patients. Br J Cancer 40:35-43.
20. Snyder JW, Greco WR, Bellnier D.A., et al. (2003). Photodynamic therapy: a means to enhanced drug delivery to tumors. Cancer Res 63: 8126-31.
21. Spagnul C, Alberto R, Gasser G., et al. (2013). Novel water-soluble Tc-99m(I)/Re(I)-porphyrin conjugates as potential multimodal agents for molecular imaging. J Inorg Biochem 122:57-65.
22. Torchilin VP. (2005). Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145-60.
23. Wang X, Danoff EJ, Sinkov N.A., et al. (2006). Highly efficient capture and long-term encapsulation of dye by catanionic surfactant vesicles. Langmuir: ACS J Surf Colloids 22:6461-4.
24. Weers J, Metzheiser B, Taylor G., et al. (2009). A gamma scintigraphy study to investigate lung deposition and clearance of inhaled amikacin-loaded liposomes in healthy male volunteers. J Aerosol Med Pulm Drug Deliv 22:131-8.
25. Yan H, Cheng C, Haouala A., et al. (2008). Distribution of free and liposomal doxorubicin after isolated lung perfusion in a sarcoma model. Ann Thorac Surg 85:1225-32.